Regeneron Pharmaceuticals, Inc. (REGN)

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

As of November 3, 2026, Regeneron Pharmaceuticals, Inc. (REGN) stock rose to $970.78, up 0.99% (+$9.52) versus the previous close. On the day, shares have traded between $953.00 and $974.34. That puts REGN near the top of its 52-week range of $591.52 to $974.34. Regeneron Pharmaceuticals, Inc. operates in the pharmaceutical preparations space and carries a market capitalization of roughly $95.99 billion, with about 485.0K shares changing hands.

Latest REGN news

• Regeneron Announces Investor Conference PresentationsYahoo Finance· Nov 2, 4:05 PM ET
• REGN Q3 deep dive: pipeline progress and core brands drive outperformanceYahoo Finance· Nov 2, 2:33 PM ET
• Regeneron's 'Strong Commercial' Q3 Underscores Core Business Health, RBC Capital Markets SaysYahoo Finance· Nov 2, 11:40 AM ET
• Should You Buy The Dip In Alnylam Stock?trefis.com· Nov 2, 9:39 AM ET
• Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resiliencebiopharmadive.com· Nov 2, 9:00 AM ET
• The top 5 analyst questions from Regeneron’s Q3 earnings callYahoo Finance· Nov 2, 8:49 AM ET
• US Stock Market Today: S&P 500 Futures Edge Higher On ISM Manufacturing TestYahoo Finance· Nov 2, 8:05 AM ET
• FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlightstocktwits.com· Nov 2, 5:36 AM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want REGN headlines, alerts and AI research in one place? Create a free account →

• $REGN back to regular scheduled programming.

  @SilverEagle· Nov 3, 11:55 AM ET· Bullish

• $REGN DARK POOL TRADE ALERT - LONG SHARES AND CALLS.. Bullish and Bearish Pressure Dark Pools.. As you can see , AI dominates the bearish side. HAPPY TRADING! $QQQ $AAL $V $COST

  @GlobalTradersAcademy· Nov 3, 11:01 AM ET· Bullish

• $ABCL $MRNA $REGN $SLS $PFE $ABCL 🧬 13 Dollar Resistance 13 dollars is in sight. But this guy won't open the door without a fight. 😂 No matter how many times you knock, it slams the brakes at $13.18 every time. Now what we need isn't the chart—it's a reason to br…

  @Stocktradesmoon· Nov 3, 10:22 AM ET· Bullish

• $ABCL $MRNA $REGN $SLS $LLY VERY BULLISH…ABcellera 🔥 🔥!!! 👀

  @Stocktradesmoon· Nov 3, 9:51 AM ET· Bullish

• $ABCL $MRNA $REGN $SLS $JNJ Now everyone is finding themselves chasing… All those sellers are now buying it up. Earnings coming up in a few days …November 9th Follow by 2 huge biotech conferences that they will be presenting at. November 9: Q3 earnings and pipeline update. Nov…

  @Stocktradesmoon· Nov 3, 9:41 AM ET· Bullish

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →